NRP1 and COVID-19: Statistical comparison using the Wilcoxon signed-rank test revealed a non-significant trend in the control group (p = 0.0625), and a significant difference in the COVID-19 group (p = 0.03125), indicating that NRP1 expression remains elevated relative to ACE2 even during infection.